Scribe Therapeutics Inc.
Ownership
Ownership Structure
Who owns Scribe Therapeutics Inc. (SCTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 36.4% of the shares are freely tradable; institutional investors hold 53.1%.
Largest Shareholders
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Health Sciences | 3.26 | 573,419 | +0.0 | 07/31/2026 |
| ARK Genomic Revolution ETF | 2.28 | 401,536 | -0.3 | 08/31/2026 |
| Franklin Biotechnology Discv A(acc)USD | 1.39 | 244,433 | +0.0 | 07/31/2026 |
| Franklin Biotechnology Discovery A | 0.77 | 135,567 | +0.0 | 08/31/2026 |
| T. Rowe Price Health Sciences Port | 0.19 | 33,034 | +0.0 | 07/31/2026 |
| ARK Genomic Revolution ETF A USD Acc | 0.11 | 19,717 | +2.6 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 0.09 | 15,461 | +0.0 | 08/31/2026 |
| JHVIT Health Sciences I | 0.05 | 9,209 | +0.0 | 07/31/2026 |
| EQ/T. Rowe Price Health Sciences IB | 0.04 | 6,506 | +0.0 | 07/31/2026 |
| Tema Healthcare AI ETF | 0.01 | 1,836 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.